Cleared Traditional

CALCIUM-ARSENAZO III REAGENT SET (K921625) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K921625 · Pointe Scientific, Inc., · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1992
Decision
37d
Days
Class 2
Risk

K921625 is an FDA 510(k) clearance for the CALCIUM-ARSENAZO III REAGENT SET. Classified as Cresolphthalein Complexone, Calcium (product code CIC), Class II - Special Controls.

Submitted by Pointe Scientific, Inc., (Lincoln Park, US). The FDA issued a Cleared decision on May 13, 1992 after a review of 37 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1145 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pointe Scientific, Inc., devices

Submission Details

510(k) Number K921625 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 1992
Decision Date May 13, 1992
Days to Decision 37 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 88d · This submission: 37d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIC Cresolphthalein Complexone, Calcium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1145
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIC Cresolphthalein Complexone, Calcium

All 98
Devices cleared under the same product code (CIC) and FDA review panel - the closest regulatory comparables to K921625.
COBAS INTEGRA REAGENT CASSETTES & ANCILLARY REAGENTS
K963292 · Roche Diagnostic Systems, Inc. · Oct 1996
IL TEST CALCIUM
K931362 · Instrumentation Laboratory CO · Feb 1994
CALCIUM TEST ITEM NUMBER 65409
K932158 · Em Diagnostic Systems, Inc. · Sep 1993
SYSTEMATE CALCIUM (EPOS APPLICATION) #65409
K905659 · Em Diagnostic Systems, Inc. · Jan 1991
COBAS READY CALCIUM REAGENT
K896224 · Roche Diagnostic Systems, Inc. · Aug 1990
ABBOTT SPECTRUM(R) CALCIUM REAGENT
K894407 · Abbott Laboratories · Sep 1989